Business Description
PetMed Express Inc
NAICS : 541940
SIC : 5912
ISIN : US7163821066
Share Class Description:
PETS: Ordinary SharesDescription
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies primarily to retail consumers.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 30.11 | |||||
| Equity-to-Asset | 0.58 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 5.47 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.05 | |||||
| Beneish M-Score | -0.46 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3.8 | |||||
| 3-Year EBITDA Growth Rate | -34.2 | |||||
| 3-Year EPS without NRI Growth Rate | -42.1 | |||||
| 3-Year FCF Growth Rate | -15.3 | |||||
| 3-Year Book Growth Rate | -6.8 | |||||
| Future 3-5Y Total Revenue Growth Rate | 8.18 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.64 | |||||
| 9-Day RSI | 24.27 | |||||
| 14-Day RSI | 26.37 | |||||
| 6-1 Month Momentum % | -52.72 | |||||
| 12-1 Month Momentum % | -69.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.32 | |||||
| Quick Ratio | 0.84 | |||||
| Cash Ratio | 0.68 | |||||
| Days Inventory | 46.64 | |||||
| Days Sales Outstanding | 2.55 | |||||
| Days Payable | 56.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 14.68 | |||||
| 3-Year Dividend Growth Rate | 3.6 | |||||
| 5-Year Yield-on-Cost % | 20.06 | |||||
| 3-Year Average Share Buyback Ratio | -1.5 | |||||
| Shareholder Yield % | 14.78 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 28.11 | |||||
| Operating Margin % | -2.11 | |||||
| Net Margin % | -1.16 | |||||
| FCF Margin % | 0.62 | |||||
| ROE % | -2.78 | |||||
| ROA % | -1.89 | |||||
| ROIC % | -10.85 | |||||
| ROC (Joel Greenblatt) % | -21.15 | |||||
| ROCE % | -4.99 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 3.12 | |||||
| PS Ratio | 0.3 | |||||
| PB Ratio | 0.86 | |||||
| Price-to-Tangible-Book | 1.4 | |||||
| Price-to-Free-Cash-Flow | 47.54 | |||||
| Price-to-Operating-Cash-Flow | 12.02 | |||||
| EV-to-EBIT | -6.39 | |||||
| EV-to-EBITDA | 124.8 | |||||
| EV-to-Revenue | 0.14 | |||||
| EV-to-FCF | 21.95 | |||||
| Price-to-Projected-FCF | 0.25 | |||||
| Price-to-Median-PS-Value | 0.18 | |||||
| Price-to-Net-Current-Asset-Value | 3.91 | |||||
| Earnings Yield (Greenblatt) % | -15.65 | |||||
| FCF Yield % | 1.99 | |||||
| Forward Rate of Return (Yacktman) % | -15.95 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers